Re­searchers point to R&D treaty to spur new in­fec­tious dis­ease treat­ments

As cur­rent in­cen­tives to pro­mote the de­vel­op­ment of new in­fec­tious dis­ease treat­ments have yet to reach their po­ten­tial, re­searchers in a new Food and Drug Law Jour­nal pa­per sug­gest form­ing a re­search and de­vel­op­ment treaty.

The “most far-reach­ing” pol­i­cy tool “may be a re­search and de­vel­op­ment treaty, which would pro­vide a fo­cal point for fu­ture glob­al co­or­di­na­tion, pro­vide a long-term com­mit­ment to fund­ing, and build on what has been learned from ex­ist­ing ap­proach­es,” au­thors Jonathan Dar­row, Michael Sin­ha, and Aaron Kessel­heim of the Pro­gram on Reg­u­la­tion, Ther­a­peu­tics and Law (POR­TAL), Har­vard Med­ical School and Brigham & Women’s Hos­pi­tal write.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.